A naukri.com initiative
Eu-Startups
1M
313
Belgian HealthTech startup Koios Care raises €1 million to monitor and treat Parkinson’s Disease with real-world data
- Belgian HealthTech startup Koios Care has secured €1 million in funding to enhance its efforts in revolutionizing the monitoring and treatment of Parkinson's Disease using AI technology to collect data from smartphones and smartwatches.
- The funding round was led by Evercurious VC, along with Astylab Ventures, the imec.istart fund, and angel investors, aiming to expand the 'Parkiwatch' tool in European clinics, support regulatory clearance, and strengthen partnerships with pharmaceutical companies and research institutions.
- Koios Care, founded by Dr Konstantinos Kyritsis and Dr Dimitris Iakovakis, focuses on improving the Quality of Life for Parkinson's patients by bridging daily life experiences with clinical care using real-world data collected passively from devices.
- The startup is addressing the global rise of Parkinson's Disease by personalizing care, streamlining clinical workflows, and assisting in drug development through data-driven insights from smartphones and smartwatches.
- By enabling clinicians and researchers to access objective real-life evidence, Koios Care aims to make more personalized decisions and enhance treatment outcomes for patients with neurological disorders.
- The platform supports patients, healthcare professionals, and pharmaceutical companies by guiding treatment decisions, monitoring outcomes, and accelerating drug development through real-world data collection.
- The funding reflects the critical need for continuous, objective data in Parkinson's care to empower patients, provide insights to medical teams, and accelerate the development of effective therapies according to Dr Iakovakis, Co-founder and CTO of Koios Care.
- Koios Care has conducted trials with 130 patients across Europe, aligning with regulatory guidelines on digital health tools, and aims to improve therapeutic decision-making and trial success rates by reflecting real-world patient outcomes.
- The innovative approach of Koios Care in monitoring Quality of Life with everyday devices is praised by Evercurious VC, highlighting the potential to reshape neurodegenerative disorders' care with personalized, data-driven management at scale.
- The startup plans to expand its focus to other brain and behavior-related conditions such as Alzheimer's and narcolepsy, aiming to address areas where real-time, real-world data is crucial for care and research.
Read Full Article
18 Likes
For uninterrupted reading, download the app